Skip to main content
Safe S.A. logo

Safe S.A. — Investor Relations & Filings

Ticker · ALSAF ISIN · FR001400F1V2 LEI · 969500DG8YK9AV60FN03 Euronext Growth Manufacturing
Open in API
Filings indexed 262 across all filing types
Latest filing 2021-01-12 Regulatory Filings
Country FR France
Listing Euronext Growth ALSAF

About Safe S.A.

https://www.safeorthopaedics.com/

Safe S.A., operating through its Safe Metal division, is a company specializing in the co-design and production of cast steel components. Utilizing green sand casting processes, the company manufactures essential parts for various industrial applications. Safe Metal positions itself as a world leader in its field, collaborating with clients to develop and supply critical components.

Recent filings

Filing Released Lang Actions
Bilan semestriel du contrat de liquidité contracté par Safe Orthopaedics avec Louis Capital Markets
Regulatory Filings Classification · 1% confidence The document is titled "Bilan semestriel du contrat de liquidité contracté par Safe Orthopaedics avec Louis Capital Markets" (Semi-annual statement of the liquidity contract entered into by Safe Orthopaedics with Louis Capital Markets). It details the status of a liquidity contract, including the number of shares and cash balance as of December 31, 2020, and transaction volumes (purchases and sales) during the second half of 2020. This type of disclosure relates to market making or share stabilization activities, which are often related to capital structure or financing arrangements, but more specifically, it is a periodic report on a specific financial arrangement. While it is a periodic report, it is not a full financial report (10-K or IR). It is a specific disclosure about a financial mechanism. Given the options, this document reports on the status of a financial arrangement (liquidity contract) and is a periodic update. It is not a general earnings release (ER), a capital raise announcement (CAP), or a director's dealing (DIRS). Since it is a specific report on a financial arrangement, and not a general regulatory filing (RNS) or a report publication announcement (RPA) announcing *other* reports, the closest fit among the specific categories is related to financing/capital, but none perfectly capture a 'liquidity contract report'. However, liquidity contracts are often managed under the umbrella of capital management or financing activities. Given the detailed nature of the report (not just an announcement of a report), it is not RPA/RNS. It is a periodic report on a financial instrument/arrangement. If we must choose the best fit, 'Capital/Financing Update' (CAP) is plausible as liquidity management is a financing activity, but the document is a *report* on an existing contract, not an *update* announcing a new financing event. Since it is a detailed, periodic report on a specific financial arrangement, and it doesn't fit the major financial reports (10-K, IR), it falls into a niche category. In many databases, periodic reports on specific financial agreements like this are often categorized under general regulatory filings (RNS) if a more specific code isn't available. However, since it details the status of a contract related to share trading/liquidity, it is a specific disclosure. Given the options, and recognizing this is a periodic report on a financial arrangement, I will classify it as a Regulatory Filing (RNS) as it is a specific, non-standard disclosure, or potentially a Capital/Financing Update (CAP) if the liquidity contract is viewed as a financing tool. Given the context of periodic reporting on share activity, RNS is the safest fallback for a specific, non-core financial report. Re-evaluating: This is a formal, periodic disclosure about the company's share liquidity mechanism, which is a regulatory requirement in some jurisdictions for companies with such agreements. It is not a general earnings report or a major statutory filing. I will classify it as RNS (Regulatory Filings) as the best fit for a specific, non-standard periodic disclosure that doesn't match the other defined categories perfectly.
2021-01-12 French
Franchissements de seuils et déclaration d'intention
Major Shareholding Notification Classification · 1% confidence The document is titled "Déclaration de franchissements de seuils et déclaration d'intention" (Declaration of threshold crossings and declaration of intent) and details changes in share ownership percentages (crossing 5%, 10%) by a major shareholder (European High Growth Opportunities Securitization Fund) in SAFE ORTHOPAEDICS, referencing French commercial code articles (L. 233-7 and L. 233-7-1). This type of mandatory disclosure regarding significant changes in shareholding is specifically covered by the category for Major Shareholding Notification (MRQ) or, given the explicit declaration of intent regarding future actions, it strongly aligns with insider/major shareholder reporting requirements. Since the core content is the notification of crossing ownership thresholds, MRQ is the most appropriate fit among the provided options, as it deals with changes in significant share ownership levels crossing thresholds.
2021-01-11 French
Safe Orthopaedics lance SORA, l’Assistant virtuel de salle d'opération pour la chirurgie du rachis
Regulatory Filings Classification · 1% confidence The document is a press release dated January 4, 2021, announcing the launch of a new product, SORA (Safe Operating Room Assistant), by Safe Orthopaedics. It details the product's features, strategic importance, and deployment timeline. This type of announcement, focusing on a new product launch, strategic development, or significant operational update that is not a mandatory periodic financial filing (like 10-K or IR) or a specific corporate action (like dividend or AGM), typically falls under general corporate news or investor relations communication. Since there is no specific category for a 'Product Launch Announcement' and it is not a transcript (CT), earnings release (ER), or management discussion (MDA), it is best classified as a general Regulatory Filing (RNS) as a catch-all for significant, non-standard announcements, or potentially an Investor Presentation (IP) if it were structured as a deck, but here it reads like a formal news release. Given the context of financial reporting databases, press releases announcing strategic developments often default to RNS if a more specific category like 'Capital/Financing Update' (CAP) or 'Management Information' (MANG) does not strictly apply. Since this is a product launch announcement, RNS is the most appropriate fallback for a non-periodic, non-financial-result-focused release.
2021-01-04 French
Safe Orthopaedics Launches SORA, The Virtual Operating Room Assistant For Spine Surgery
Regulatory Filings Classification · 1% confidence The document is a press release dated January 4th, 2021, announcing the launch of a new product, 'SORA, The Virtual Operating Room Assistant For Spine Surgery.' It details the features, benefits, and planned deployment timeline for this innovation. This type of announcement, focusing on a new product launch and strategic development, is characteristic of a general corporate announcement rather than a formal regulatory filing like a 10-K, an earnings release (ER), or a specific financial report (IR, AR). Since it is a general announcement about company activity and strategy, and does not fit the specific categories like Director's Dealing (DIRS), Capital Change (CAP), or Dividend Notice (DIV), it falls best under the general Regulatory Filings/Announcements category (RNS) as a fallback for significant, non-standard corporate news, or potentially as a general Investor Presentation (IP) if it were structured as a deck, but given the press release format, RNS is the most appropriate general classification for significant, non-standard news not covered by other specific codes.
2021-01-04 English
Franchissement de seuils
Major Shareholding Notification Classification · 1% confidence The document is titled "Déclaration de franchissements de seuils et déclaration d'intention" (Declaration of crossing thresholds and declaration of intent) and details changes in share ownership and voting rights by a major shareholder (European High Growth Opportunities Securitization Fund) crossing thresholds (5%, 10%, 15%) in SAFE ORTHOPAEDICS. This type of mandatory disclosure regarding significant changes in shareholding is specifically covered by regulations concerning insider transactions or major shareholding notifications. Reviewing the definitions, 'Director's Dealing' (DIRS) covers personal share transactions by directors, which is too narrow. 'Major Shareholding Notification' (MRQ) is defined as 'Notification of changes in significant share ownership levels (crossing thresholds)'. This perfectly matches the content, which explicitly details crossing ownership thresholds (5%, 10%, 15%) and includes the required declaration of intent.
2021-01-04 French
Franchissements de seuils
Major Shareholding Notification Classification · 1% confidence The document is titled "Déclaration de franchissements de seuils (articles L. 233-7 et L. 233-7-1 du code de commerce)" which translates to 'Declaration of crossing thresholds (Articles L. 233-7 and L. 233-7-1 of the Commercial Code)'. This type of filing specifically reports changes in significant share ownership, where an entity crosses statutory thresholds (like 5%). This directly corresponds to the definition of Major Shareholding Notification (MRQ), which covers 'Notification of changes in significant share ownership levels (crossing thresholds)'. The content details the exact percentage changes and the number of shares held by European High Growth Opportunities Manco.
2020-12-28 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.